PATENT CLAIM ANALYSIS

Application Number: 15981696
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "221000"]

Abstract:
Methods are provided herein for selectively killing senescent cells and for treating senescence-associated diseases and disorders by administering a senolytic agent. Senescence-associated diseases and disorders treatable by the methods using the senolytic agents described herein include cardiovascular diseases and disorders associated with or caused by arteriosclerosis, such as atherosclerosis; idiopathic pulmonary fibrosis; chronic obstructive pulmonary disease; osteoarthritis; senescence-associated ophthalmic diseases and disorders; and senescence-associated dermatological diseases and disorders.

Claim (Index 7):
The method of  claim 1 , wherein the senescent cell is a fibroblast.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 93.0
- Lexical Diversity: 1.58333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15950965', '15955542', '15114762', '15827539', '15956613']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8933498729646758
- 35 USC 102 Novelty (BERT): 0.586987089002551
- Combined Prediction Score: 0.8627135945684633
- Mean Citation Score: 673.82474
- Max Citation Score: 695.2333
- Similarity Product: 394.43466633874175

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test